Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and during Exercise

Diabetes Technology and Therapeutics

Volumn 18, Issue 9, 2016, Pages 561-567

  Taleb, Nadine ^a,b   Emami, Ali ^a,c   Suppere, Corinne ^a   Messier, Virginie ^a   Legault, Laurent ^d   Chiasson, Jean Louis ^e,f   Rabasa Lhoret, Rémi ^a,b,f   Haidar, Ahmad ^g  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Montreal Diabetes Research Center   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; MEASUREMENT ACCURACY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; ANALYSIS; BLOOD; COMPARATIVE STUDY; DEVICES; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REST; YOUNG ADULT;

EID: 84987720579     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2015.0394     Document Type: Article

References (30)

1. Karter AJ, Parker MM, Moffet HH, et al.: Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29:1757-1763.
2. Klonoff DC: Continuous glucosemonitoring roadmap for 21st century diabetes therapy. Diabetes Care 2005;28:1231-1239.
3. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999;277:E561-E571.
4. Brazeau A-S, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 2008;31:2108-2109.
5. Diabetes Research in Children Network (Direcnet) Study Group; Buckingham BA, Kollman C, Beck R, Kalajian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, TamborlaneWV: Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006;8:318-325.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
7. Hovorka R: Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011;7:385-395.
8. Facchinetti A, Del Favero S, Sparacino G, Cobelli C: Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices. Med Biol Eng Comput 2015;53:1259-1269.
9. Desalvo D, Buckingham B: Continuous glucose monitoring: current use and future directions. Curr Diab Rep 2013;13:657-662.
10. Christiansen M, Bailey T, Watkins E, et al.:Anew-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013;15:881-888.
11. Wilson DM, Beck RW, Tamborlane WV, et al.: The accuracy of the FreeStyle navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007;30:59-64.
12. Fayolle C, Brun JF, Bringer J, et al.: Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity. Diabetes Metab 2006;32:313-320.
13. Adolfsson P, Nilsson S, Lindblad B: Continuous glucose monitoring system during physical exercise in adolescents with type 1 diabetes. Acta Paediatr 2011;100:1603-1609.
14. Maahs DM, DeSalvo D, Pyle L, et al.: Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care 2015;38:e158-e159.
15. International Organization for Standardization: in vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva Int Organ Stand ISO 151972013.
16. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for selfmonitoring of blood glucose. Diabetes Care 1987;10:622-628.
17. Leelarathna L, Nodale M, Allen JM, et al.: Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems. Diabetes Technol Ther 2013;15:143-149.
18. Calhoun P, Lum J, Beck RW, Kollman C: performance comparison of the medtronic Sof-sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013;15:1-4.
19. Keenan DB, Mastrototaro JJ, Zisser H, et al.: Accuracy of the Enlite 6-day glucose sensor with Guardian and Veo calibration algorithms. Diabetes Technol Ther 2012;14:225-231.
20. Matuleviciene V, Joseph JI, Andelin M, et al.: A clinical trial of the accuracy and treatment experience of theDexcomG4 sensor (Dexcom G4 system) and Enlite sensor (Guardian REAL-Time system) tested simultaneously in ambulatory patients with type 1 diabetes. Diabetes Technol Ther 2014;16:759-767.
21. Kropff J, Bruttomesso D, Doll W, et al.: Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions. Diabetes Obes Metab 2015;17:343-349.
22. Vashist S: Continuous glucose monitoring systems: a review. Diagnostics 2013;3:385-412.
23. Nakamura K, Balo A: The accuracy and efficacy of the Dexcom G4 platinum continuous glucose monitoring system. J Diabetes Sci Technol 2015;9:1021-1026.
24. Kumareswaran K, Elleri D, Allen JM, et al.: Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy. Diabetes Technol Ther 2013;15:223-229.
25. Bequette BW: Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms. J Diabetes Sci Technol 2010;4:404-418.
26. Ricci F, Caprio F, Poscia A, et al.: Toward continuous glucose monitoringwith planarmodified biosensors andmicrodialysis. Study of temperature, oxygen dependence and in vivo experiment. Biosens Bioelectron 2007;22:2032-2039.
27. Haidar A, Legault L, Messier V, et al.: Comparison of dualhormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 2014;8587:1-10.
28. Haidar A, Legault L, Matteau-Pelletier L, et al.: Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 2015;3:595-604.
29. Iscoe KE, Campbell JE, Jamnik V, Perkins BA, Riddell MC: Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther 2006;8:627-635.
30. Damiano ER, McKeon K, El-Khatib FH, et al.: A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol 2014;8:699-708.